Inventor · disambiguated record
Sylvie Colin
Also filed as: COLIN SYLVIE
15 granted patents·11 pending applications·29 citations·filing 2004–2018
89Inventor score
Top patents by PatentIndex Score
26 records- 0186US7674770B2Anti-tumor drug, medicament, composition, and use thereofGENE SIGNAL INT SA·Filed 2007·Granted Mar 9, 2010·4 cites·19 claims
- 0284US9539306B2Anti-tumor drug, medicament, composition, and use thereofGENE SIGNAL INT SA·Filed 2014·Granted Jan 10, 2017·3 cites·9 claims
- 0379US8742067B2Anti-tumor drug, medicament, composition, and use thereofAL MAHMOOD SALMAN·Filed 2008·Granted Jun 3, 2014·1 cites·9 claims
- 0478US7993665B2Wound healing agent and compositionGENE SIGNAL INT SA·Filed 2008·Granted Aug 9, 2011·4 cites·9 claims
- 0576US8133877B2Composition comprising an antisense sequence implicated in the regulation of angiogenesisAL-MAHMOOD SALMAN·Filed 2009·Granted Mar 13, 2012·3 cites·4 claims
- 0673US9682144B2Composition comprising inhibitors of IRS-1 and of VEGFTHORIN ERIC·Filed 2012·Granted Jun 20, 2017·4 cites·2 claims
- 0771US7553492B2Pharmaceutical compositions containing angiogenic activatorsGENE SIGNAL·Filed 2004·Granted Jun 30, 2009·9 cites·3 claims
- 0868US8188044B2Anti-tumor drug, medicament, composition, and use thereofCOLIN SYLVIE·Filed 2009·Granted May 29, 2012·0 cites·6 claims
- 0967US8372810B2Anti-tumor drug, medicament, composition, and use thereofGENE SIGNAL INT SA·Filed 2008·Granted Feb 12, 2013·0 cites·25 claims
- 1067US8288334B2Peptides for wound healingAL-MAHMOOD SALMAN·Filed 2010·Granted Oct 16, 2012·1 cites·16 claims
- 1165US7906621B2Anti-tumor drug, medicament, composition, and use thereofGENE SIGNAL INT SA·Filed 2007·Granted Mar 15, 2011·0 cites·13 claims
- 1255US9206236B2Peptides for treating cancerAL-MAHMOOD SALMAN·Filed 2011·Granted Dec 8, 2015·0 cites·5 claims
- 1354US7803906B2Composition comprising an angiogenesis related proteinGENE SIGNAL INT SA·Filed 2004·Granted Sep 28, 2010·0 cites·6 claims
- 1451US2010135985A1Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them an uses thereofGENE SIGNAL SAS·Filed 2006·Application pending·0 cites
- 1544US8383591B2Peptides for treating cancerGENE SIGNAL INTERNAT S A·Filed 2010·Granted Feb 26, 2013·0 cites·15 claims
- 1644US2008194478A1Wound healing agent and compositionGENE SIGNAL INT SA·Filed 2007·Application pending·0 cites
- 1742US2020172618A1Cd9p-1-targeting antibody and uses thereofGENE SIGNAL INT SA·Filed 2018·Application pending·0 cites
- 1841US2013143947A1Injectable Pharmaceutical Composition for Preventing, Stabilising and/or Inhibiting Pathological Neovascularization-Related ConditionsAL-MAHMOOD SALMAN·Filed 2011·Application pending·0 cites
- 1940US2015283165A1Use of an inhibitor of irs-1 for treating skin disordersGENE SIGNAL INT SA·Filed 2013·Application pending·0 cites
- 2039US2012041047A1Injectable Pharmaceutical Composition for Preventing, Stabilizing and/or Inhibiting Pathological Neovascularization-Related ConditionsAL-MAHMOOD SALMAN·Filed 2010·Application pending·0 cites
- 2139US2013157949A1Novel Peptides for Wound HealingAL-MAHMOOD SALMAN·Filed 2011·Application pending·0 cites
- 2238US9359604B2Inhibitor of IRS-1 for treating skin disordersAL-MAHMOOD SALMAN·Filed 2012·Granted Jun 7, 2016·0 cites·9 claims
- 2337US2011104169A1Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applicationsGENE SIGNAL INTERNAT·Filed 2010·Application pending·0 cites
- 2433US2013004511A1Composition comprising inhibitors of irs-1 and of vegfGENE SIGNAL INT SA·Filed 2011·Application pending·0 cites
- 2532US2017173106A1Polypeptide Fragments of 168A-T2 and Compositions Comprising Them for Use in Treating CancerGENE SIGNAL INT SA·Filed 2015·Application pending·0 cites
- 2631US2017035693A1Sterile Emulsion Comprising a Stable Phosphorothioate OligonucleotideGENE SIGNAL INT SA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sylvie Colin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →